BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23957733)

  • 1. Fine mapping of V(D)J recombinase mediated rearrangements in human lymphoid malignancies.
    Halper-Stromberg E; Steranka J; Giraldo-Castillo N; Fuller T; Desiderio S; Burns KH
    BMC Genomics; 2013 Aug; 14():565. PubMed ID: 23957733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining.
    Haluska FG; Finver S; Tsujimoto Y; Croce CM
    Nature; 1986 Nov 13-19; 324(6093):158-61. PubMed ID: 3097550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints.
    Raghavan SC; Kirsch IR; Lieber MR
    J Biol Chem; 2001 Aug; 276(31):29126-33. PubMed ID: 11390401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V(D)J recombinase-mediated processing of coding junctions at cryptic recombination signal sequences in peripheral T cells during human development.
    Murray JM; O'Neill JP; Messier T; Rivers J; Walker VE; McGonagle B; Trombley L; Cowell LG; Kelsoe G; McBlane F; Finette BA
    J Immunol; 2006 Oct; 177(8):5393-404. PubMed ID: 17015725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalent involvement of illegitimate V(D)J recombination in chromosome 9p21 deletions in lymphoid leukemia.
    Kitagawa Y; Inoue K; Sasaki S; Hayashi Y; Matsuo Y; Lieber MR; Mizoguchi H; Yokota J; Kohno T
    J Biol Chem; 2002 Nov; 277(48):46289-97. PubMed ID: 12228235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the pathogenic potential of the V(D)J recombinase by interlocus immunoglobulin light-chain gene rearrangement.
    Bailey SN; Rosenberg N
    Mol Cell Biol; 1997 Feb; 17(2):887-94. PubMed ID: 9001243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V(D)J recombinase mediated inter-chromosomal HPRT alterations at cryptic recombination signal sequences in peripheral human T cells.
    Messier TL; O'Neill JP; Finette BA
    Hum Mutat; 2006 Aug; 27(8):829. PubMed ID: 16835902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistent breakage between consensus recombinase heptamers of chromosome 9 DNA in a recurrent chromosomal translocation of human T cell leukemia.
    Tycko B; Reynolds TC; Smith SD; Sklar J
    J Exp Med; 1989 Feb; 169(2):369-77. PubMed ID: 2536065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The t(8;14) chromosome translocation of the Burkitt lymphoma cell line Daudi occurred during immunoglobulin gene rearrangement and involved the heavy chain diversity region.
    Haluska FG; Tsujimoto Y; Croce CM
    Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6835-9. PubMed ID: 3116544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA sequence analysis of interlocus recombination between the human T-cell receptor gamma variable (GV) and beta diversity-joining (BD/BJ) sequences on chromosome 7 (inversion 7).
    Ballinger SW; Judice SA; Nicklas JA; Albertini RJ; O'Neill JP
    Environ Mol Mutagen; 2002; 40(2):85-92. PubMed ID: 12203400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt.
    Chen CL; Woo MH; Neale GA; Goorha RM; Fuscoe JC; Behm FG; Mathew S; Relling MV
    Mutat Res; 1998 Jul; 403(1-2):113-25. PubMed ID: 9726012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for secondary V(D)J recombination in oncogenic chromosomal translocations?
    Davila M; Foster S; Kelsoe G; Yang K
    Adv Cancer Res; 2001; 81():61-92. PubMed ID: 11430596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. V(D)J recombinase binding and cleavage of cryptic recombination signal sequences identified from lymphoid malignancies.
    Zhang M; Swanson PC
    J Biol Chem; 2008 Mar; 283(11):6717-27. PubMed ID: 18187418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VDJ recombinase-mediated TCR β locus gene usage and coding joint processing in peripheral T cells during perinatal and pediatric development.
    Murray JM; Messier T; Rivers J; O'Neill JP; Walker VE; Vacek PM; Finette BA
    J Immunol; 2012 Sep; 189(5):2356-64. PubMed ID: 22855706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cells.
    Chen CL; Fuscoe JC; Liu Q; Relling MV
    Blood; 1996 Sep; 88(6):2210-8. PubMed ID: 8822941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase.
    Vanasse GJ; Halbrook J; Thomas S; Burgess A; Hoekstra MF; Disteche CM; Willerford DM
    J Clin Invest; 1999 Jun; 103(12):1669-75. PubMed ID: 10377173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessibility control of V(D)J recombination.
    Cobb RM; Oestreich KJ; Osipovich OA; Oltz EM
    Adv Immunol; 2006; 91():45-109. PubMed ID: 16938538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapy.
    Fuscoe JC; Knapp GW; Hanley NM; Setzer RW; Sandlund JT; Pui CH; Relling MV
    Mutat Res; 1998 Nov; 419(1-3):107-21. PubMed ID: 9804912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted transposition by the V(D)J recombinase.
    Lee GS; Neiditch MB; Sinden RR; Roth DB
    Mol Cell Biol; 2002 Apr; 22(7):2068-77. PubMed ID: 11884595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of the t(8;14)(q24;q11) chromosomal breakpoint junctions in the T-cell leukemia line MOLT-16.
    Shima-Rich EA; Harden AM; McKeithan TW; Rowley JD; Diaz MO
    Genes Chromosomes Cancer; 1997 Dec; 20(4):363-71. PubMed ID: 9408752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.